1. Home
  2. IRON
  3. IRON News

Latest Disc Medicine Inc. (IRON) News on November 18, 2025

IRON

MT Newswires

4 days ago

Disc Medicine Insider Sold Shares Worth $2,540,923, According to a Recent SEC Filing

A Fresh Look at Disc Medicine’s Valuation After Bitopertin NDA Submission and Positive Phase 2 Data
IRON

Simply Wall St.

2 months ago

A Fresh Look at Disc Medicine’s Valuation After Bitopertin NDA Submission and Positive Phase 2 Data

IRON

MT Newswires

2 months ago

Disc Medicine Submits New Drug Application to FDA for Bitopertin to Treat Patients With Erythropoietic Protoporphyria

Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
IRON

GlobeNewswire

2 months ago

Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)

Leerink Partners Reiterates a Buy Rating on Disc Medicine (IRON) With an $85 Price Target
IRON

Insider Monkey

5 months ago

Leerink Partners Reiterates a Buy Rating on Disc Medicine (IRON) With an $85 Price Target

Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating
IRON

Insider Monkey

5 months ago

Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating

Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
IRON

GlobeNewswire

5 months ago

Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress

IRON

Investing.com

5 months ago

Raymond James bullish on biotech firms on favorable valuation

Disc Medicine to Participate in Upcoming Investor Conferences
IRON

GlobeNewswire

6 months ago

Disc Medicine to Participate in Upcoming Investor Conferences

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress
IRON

GlobeNewswire

6 months ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress

Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference
IRON

GlobeNewswire

6 months ago

Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation
IRON

Simply Wall St.

6 months ago

Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation

Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
IRON

GlobeNewswire

6 months ago

Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update

Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF)
IRON

GlobeNewswire

7 months ago

Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF)

Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode?
IRON

Insider Monkey

8 months ago

Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode?

IRON

MT Newswires

8 months ago

Disc Medicine Insider Sold Shares Worth $2,831,987, According to a Recent SEC Filing

With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing
IRON

Simply Wall St.

8 months ago

With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing

Victoria’s Secret, Bitdeer, and More Stocks See Activist Action
IRON

Barrons.com

8 months ago

Victoria’s Secret, Bitdeer, and More Stocks See Activist Action

All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy
IRON

Zacks

8 months ago

All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy

Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know
IRON

Zacks

9 months ago

Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know

IRON

MT Newswires

9 months ago

Disc Medicine's Annual Loss Widens in 2024

IRON

MT Newswires

9 months ago

TD Cowen Initiates Coverage on Disc Medicine With Buy Rating

Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
IRON

GlobeNewswire

9 months ago

Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Disc Medicine to Participate in Upcoming Investor Conferences
IRON

GlobeNewswire

9 months ago

Disc Medicine to Participate in Upcoming Investor Conferences

Disc Medicine, Inc. (IRON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
IRON

Zacks

9 months ago

Disc Medicine, Inc. (IRON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Disc raises $225.5m as it eyes approval of rare skin disorder drug
IRON

Pharmaceutical Technology

10 months ago

Disc raises $225.5m as it eyes approval of rare skin disorder drug

IRON

MT Newswires

10 months ago

Disc Medicine Prices Upsized $225.5 Million Offering

Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
IRON

GlobeNewswire

10 months ago

Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
IRON

GlobeNewswire

10 months ago

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

IRON

MT Newswires

10 months ago

Disc Medicine Reports 'Positive' Feedback From FDA Meeting

IRON

MT Newswires

10 months ago

Wedbush Raises Price Target on Disc Medicine to $90 From $83, Keeps Outperform Rating

Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission
IRON

GlobeNewswire

10 months ago

Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission

Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
IRON

GlobeNewswire

10 months ago

Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)
IRON

GlobeNewswire

10 months ago

Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)

Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025
IRON

GlobeNewswire

10 months ago

Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025

An Intrinsic Calculation For Disc Medicine, Inc. (NASDAQ:IRON) Suggests It's 29% Undervalued
IRON

Simply Wall St.

a year ago

An Intrinsic Calculation For Disc Medicine, Inc. (NASDAQ:IRON) Suggests It's 29% Undervalued

IRON

MT Newswires

a year ago

Disc Medicine Insider Sold Shares Worth $1,251,357, According to a Recent SEC Filing

IRON

MT Newswires

a year ago

Disc Medicine Presents Data Showing Potential Benefits of 3 Investigational Drugs

Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
IRON

GlobeNewswire

a year ago

Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
IRON

GlobeNewswire

a year ago

Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting

Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
IRON

TipRanks

a year ago

Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks

Disc Medicine to Participate in Upcoming Investor Conferences
IRON

GlobeNewswire

a year ago

Disc Medicine to Participate in Upcoming Investor Conferences

IRON

MT Newswires

a year ago

Wedbush Raises Disc Medicine Price Target to $83 From $75, Maintains Outperform Rating

IRON

MT Newswires

a year ago

Disc Medicine's Q3 Net Loss Widens

Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update
IRON

GlobeNewswire

a year ago

Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

Disc Medicine secures $200m financing to support trials
IRON

Clinical Trials Arena

a year ago

Disc Medicine secures $200m financing to support trials

IRON

MT Newswires

a year ago

Disc Medicine Gets $200 Million Loan From Hercules Capital

Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
IRON

GlobeNewswire

a year ago

Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
IRON

GlobeNewswire

a year ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

IRON

MT Newswires

a year ago

Morgan Stanley Upgrades Disc Medicine to Overweight From Equalweight, Price Target is $85

Disc teases potential NDA for rare skin disorder drug
IRON

Pharmaceutical Technology

a year ago

Disc teases potential NDA for rare skin disorder drug

IRON

MT Newswires

a year ago

Disc Medicine to Initiate Apollo Trial After Phase 2 Meeting With FDA for Bitopertin in Erythropoietic Protoporphyria

IRON

MT Newswires

a year ago

Wedbush Adjusts Disc Medicine Price Target to $75 From $60, Maintains Outperform Rating

Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval
IRON

GlobeNewswire

a year ago

Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
IRON

GlobeNewswire

a year ago

Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week
IRON

GlobeNewswire

a year ago

Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week

Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer
IRON

GlobeNewswire

a year ago

Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer

IRON

MT Newswires

a year ago

Scotiabank Initiates Disc Medicine at Sector Outperform

Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
IRON

GlobeNewswire

a year ago

Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
IRON

GlobeNewswire

a year ago

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer

Disc Medicine to Participate in Upcoming Investor Conferences
IRON

GlobeNewswire

a year ago

Disc Medicine to Participate in Upcoming Investor Conferences

IRON

MT Newswires

a year ago

Wells Fargo Initiates Disc Medicine at Overweight With $75 Price Target

Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation
IRON

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation

Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update
IRON

GlobeNewswire

a year ago

Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update

Bitfarms Technologies, Vestis, and More Stocks See Action From Activist Investors
IRON

Barrons.com

a year ago

Bitfarms Technologies, Vestis, and More Stocks See Action From Activist Investors

IRON

MT Newswires

a year ago

Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing

IRON

MT Newswires

a year ago

BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating

IRON

MT Newswires

a year ago

Wedbush Raises Disc Medicine Price Target to $57 From $43, Maintains Outperform Rating

IRON

MT Newswires

a year ago

Disc Medicine Prices $178 Million Common Stock Offering; Shares Rise

Disc Medicine Announces Underwritten Offering of Common Stock
IRON

GlobeNewswire

a year ago

Disc Medicine Announces Underwritten Offering of Common Stock

Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
IRON

GlobeNewswire

a year ago

Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
IRON

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
IRON

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
IRON

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
IRON

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

IRON

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
IRON

AFP

a year ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
IRON

Investor's Business Daily

a year ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
IRON

The Wall Street Journal

a year ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Disc Medicine to Participate in the Jefferies Global Healthcare Conference
IRON

GlobeNewswire

a year ago

Disc Medicine to Participate in the Jefferies Global Healthcare Conference

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
IRON

GlobeNewswire

2 years ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress

Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
IRON

GlobeNewswire

2 years ago

Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference

IRON

GuruFocus.com

2 years ago

Disc Medicine Inc (IRON) Reports Q1 2024 Earnings: A Detailed Financial Overview

Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
IRON

GlobeNewswire

2 years ago

Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
IRON

Zacks

2 years ago

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More

Disc Medicine (IRON) Down on Mixed Results From AURORA Study
IRON

Zacks

2 years ago

Disc Medicine (IRON) Down on Mixed Results From AURORA Study

Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study
IRON

Investor's Business Daily

2 years ago

Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study

Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
IRON

GlobeNewswire

2 years ago

Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)

IRON

GuruFocus.com

2 years ago

Disc Medicine Inc (IRON) Reports Earnings: A Detailed Look at Fiscal Performance

Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
IRON

GlobeNewswire

2 years ago

Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
IRON

GlobeNewswire

2 years ago

Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
IRON

GlobeNewswire

2 years ago

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer

Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
IRON

GlobeNewswire

2 years ago

Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
IRON

GlobeNewswire

2 years ago

Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera

Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
IRON

GlobeNewswire

2 years ago

Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer

WSFS (WSFS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
IRON

Zacks

2 years ago

WSFS (WSFS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

ONE Gas Fourth Quarter and Year End 2023 Conference Call and Webcast Scheduled
IRON

PR Newswire

2 years ago

ONE Gas Fourth Quarter and Year End 2023 Conference Call and Webcast Scheduled

Plexus (PLXS) Reports Q1 Earnings: What Key Metrics Have to Say
IRON

Zacks

2 years ago

Plexus (PLXS) Reports Q1 Earnings: What Key Metrics Have to Say

Kohl's Insider Ups Holding By 4,048% During Year
IRON

Simply Wall St.

2 years ago

Kohl's Insider Ups Holding By 4,048% During Year

IRON

GuruFocus.com

2 years ago

Park National Corp (PRK) Reports Decline in 2023 Earnings Amid Economic Challenges

Share on Social Networks: